Drug Information
| General Information | ||||||
|---|---|---|---|---|---|---|
| Drug ID |
DR00387
|
|||||
| Drug Name |
Omeprazole
|
|||||
| Synonyms |
(-)-Omeprazole; 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole; 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; AGI-010; AULCER; Antra; Antra MUPS; Audazol; Axagon; Belmazol; Ceprandal; DM-3458; Danlox; Demeprazol; Desec; Dizprazol; Dudencer; Elgam; Emeproton; Emilok; Epirazole; Erbolin; Esomeprazol; Esomeprazole; Esomperazole; Esopral; Exter; Gasec; Gastrimut; Gastroloc; Gibancer; H 168-68; H 168/68; H-168/68; Indurgan; Inhibitron; Inhipump; Lensor; Logastric; Lomac; Losec; Losec (TN); Losec, Omesec, Prilosec, Zegerid, Omeprazole; Lucen; Mepral; Miol; Miracid; Mopral; Morecon; Nexium; Nexium IV; Nilsec; Nopramin; Nuclosina; O0359; OMEP; OMZ; Ocid; Olexin; Olit; Omapren; Omebeta; Omebeta 20; Omed; Omegast; Omepradex; Omepral; Omeprazol; Omeprazol [INN-Spanish]; Omeprazole (JAN/USP/INN); Omeprazole [USAN:INN:BAN:JAN]; Omeprazole delayed-release; Omeprazole magnesium; Omeprazolum; Omeprazolum [INN-Latin]; Omeprazon; Omeprazone; Omeprol; Omesek; Omez; Omezol; Omezolan; Omid; Omisec; Omizac; Ompanyt; Ortanol; Osiren; Ozoken; Paprazol; Parizac; Pepticum; Pepticus; Peptilcer; Prazentol; Prazidec; Prazolit; Prilosec; Prilosec (TN); Prilosec OTC; Procelac; Proclor; Prysma; Ramezol; Regulacid; Result; SAN-15; Sanamidol; Secrepina; Tedec Ulceral; Ulceral; Ulcesep; Ulcometion; Ulcozol; Ulcsep; Ulsen; Ultop; Ulzol; Victrix; Zefxon; Zegerid; Zepral; Zimor; Zoltum
|
|||||
| Drug Type |
Small molecular drug
|
|||||
| Indication | Gastroesophageal reflux disease [ICD11: DA22] | Approved | [1] | |||
| Therapeutic Class |
Antiulcer Agents
|
|||||
| Structure |
|
 |
||||
| 3D MOL | 2D MOL | |||||
| Formula |
C17H19N3O3S
|
|||||
| Canonical SMILES |
CC1=CN=C(C(=C1OC)C)CS(=O)C2=NC3=C(N2)C=C(C=C3)OC
|
|||||
| InChI |
InChI=1S/C17H19N3O3S/c1-10-8-18-15(11(2)16(10)23-4)9-24(21)17-19-13-6-5-12(22-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20)
|
|||||
| InChIKey |
SUBDBMMJDZJVOS-UHFFFAOYSA-N
|
|||||
| CAS Number |
CAS 73590-58-6
|
|||||
| Pharmaceutical Properties | Molecular Weight | 345.4 | Topological Polar Surface Area | 96.3 | ||
| Heavy Atom Count | 24 | Rotatable Bond Count | 5 | |||
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 6 | |||
| XLogP |
2.2
|
|||||
| PubChem CID | ||||||
| PubChem SID |
10321754
, 11112840
, 11398365
, 11466521
, 11467641
, 11486042
, 11528599
, 12013167
, 14753960
, 14875946
, 22391484
, 24897870
, 26751452
, 26751453
, 26759296
, 29223683
, 3281991
, 46386973
, 46487906
, 46509065
, 4696242
, 47365309
, 47589088
, 47589089
, 48035237
, 48170542
, 48414255
, 48416351
, 49681572
, 49698521
, 49834935
, 50100529
, 50103932
, 5212304
, 53788700
, 56313300
, 56313696
, 56313928
, 56422106
, 57322340
, 640212
, 7847521
, 7980199
, 80295314
, 81093370
, 8152819
, 85174452
, 855576
, 85788870
, 9532
|
|||||
| ChEBI ID |
ChEBI:7772
|
|||||
| TTD Drug ID | ||||||
| DT(s) Transporting This Drug | P-GP | Transporter Info | P-glycoprotein 1 | Substrate | [2] | |
| References | ||||||
| 1 | Omeprazole was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
| 2 | A novel screening strategy to identify ABCB1 substrates and inhibitors. Naunyn Schmiedebergs Arch Pharmacol. 2009 Jan;379(1):11-26. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.